The majority of our principal investigators run sites allowing for a deeper understanding of their research projects as well as the team of professionals and trainees that have made this work central to their life’s work.
Listed here are all of the currently published Department of Pediatrics’ labs across our divisions.
Mavers Lab
Melissa Mavers, MD, PhD
Division of Hematology & Oncology
Work in our lab focuses on immune regulation of graft-versus-host disease (GVHD), a debilitating and potentially fatal complication of hematopoietic stem cell transplantation (HSCT). HSCT can cure high-risk malignancies and other diseases of the blood and bone marrow, yet success is limited as many patients develop this devastating complication.
We aim to elucidate the biological mechanisms underlying immune tolerance in HSCT and develop approaches to enhance regulatory immune cells for GVHD prevention and treatment. Our goal is to use a bench-to-bedside approach to develop a cellular therapy for GVHD, engineering viable approaches to prevention and cure, and thereby make HSCT a safer way to cure cancer and other blood diseases, giving survivors long, healthy lives.
Morley Lab
S. Celeste Morley, MD, PhD
Division of Infectious Diseases
Up, down and all around. Immune cells are constantly in motion as they seek to defend the host against pathogens. Dramatic cell shape changes induced by alterations in the underlying actin cytoskeleton provide the structural framework required for cell motility.
Neonatal Neurology & Physiology Research Lab
Zachary A. Vesoulis, MD, MSCI
Division of Newborn Medicine
Our lab focuses on understanding the physiologic basis for brain injury in neonates, as well as the development of new methodologies for prediction of neurologic injury. The ultimate goal of these efforts is the development of new strategies for neonatal neuroprotection.
Orscheln Lab
Rachel C. Orscheln, MD
Division of Infectious Diseases
Treatments and outcomes of bone and joint infection in children.
Orvedahl Lab
Anthony Orvedahl, MD, PhD
Division of Infectious Diseases
We utilize a combination of hypothesis-driven and discovery-based approaches to understand factors that regulate host immune responses to infectious and sterile triggers of severe inflammation. We focus on the cytoplasmic recycling pathway of autophagy, which we found protected macrophages against cytokine-induced cell death and mice against fatal cytokine storm syndrome. However, the relative protective or pathogenic role of autophagy in macrophage survival remains unclear in different contexts. Preliminary findings point towards a critical intersection of these processes with immunometabolism. We are leveraging this experience and developing novel tools to understand the commonalities and peculiarities of cytokine storm syndromes triggered by various etiologies including SARS-CoV-2. The ultimate goal is to develop host-directed therapies for infectious and inflammatory disorders.
Pediatric Storage Disorders Lab
Jonathan D. Cooper, PhD
Division of Genetics and Genomic Medicine
The Pediatric Storage Disorders Lab (PDSL), studies the pathogenesis of the neuronal ceroid lipofuscinoses (NCLs, or Batten disease), and other similar neurodegenerative lysosomal storage disorders.
Perlmutter Lab
David Perlmutter, MD
Division of Gastroenterology, Hepatology & Nutrition
David Perlmutter is internationally recognized for his research on the pathobiology of α1-antitrypsin deficiency, a rare disease in which a misfolded protein causes chronic liver failure and hepatocellular carcinoma. His work has led to advances in understanding the basic mechanisms of liver fibrosis and carcinoma and novel therapeutic strategies. Together with collaborators he has discovered a pipeline of drugs that can eliminate misfolded proteins and reverse the liver disease in model organisms. One of these drugs has advanced to phase II/III clinical trials. The class of drugs may also be utilized for other diseases caused by misfolded proteins, including Alzheimer’s disease and other age-dependent degenerative diseases.
Rosen Lab
David A. Rosen, MD, PhD
Division of Infectious Diseases
Our lab focuses on the pathogenesis of Klebsiella pneumoniae (Kp) — an opportunistic pathogen that is increasingly becoming multidrug resistant. As a result, resistant Kp is deemed “urgent” by the CDC and a “priority pathogen” by the World Health Organization.
Rubenstein Lab
Ronald Rubenstein, MD, PhD
Division of Allergy & Pulmonary Medicine
The Rubenstein lab focuses on the mechanisms by which small molecules may improve the function of mutant proteins that cause disease due to abnormal biogenesis and trafficking. These studies initially focused on epithelial ion channels relevant to Cystic Fibrosis, and have expanded to address fundamental biologic questions related to the regulation of protein biogenesis and trafficking in a number of other diseases and conditions.
Find your place at WashU
Browse and learn about open positions at Washington University @ jobs.wustl.edu.